Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Applied DNA Sciences | APDN | Sep 3, 2024 | 1.52 | -20.42 |
Applied Industrial Technologies | AIT | Sep 3, 2024 | 198.55 | -3.20 |
Applied Materials | AMAT | Sep 3, 2024 | 183.37 | -7.04 |
Applied Optoelectronics | AAOI | Sep 3, 2024 | 12.26 | +8.02 |
Applied Therapeutics | APLT | Sep 3, 2024 | 5.86 | -7.57 |
Applied UV A Pref | AUVIP | Sep 3, 2024 | 0.64 | 0.00 |
Applovin A | APP | Sep 3, 2024 | 88.13 | -5.10 |
AppTech Payments | APCX | Sep 3, 2024 | 0.76 | -2.56 |
Aprea Therapeutics | APRE | Sep 3, 2024 | 3.33 | -2.88 |
AptarGroup | ATR | Sep 3, 2024 | 150.04 | -2.06 |
Aptevo Therapeutics | APVO | Sep 3, 2024 | 0.35 | -3.47 |
Aptiv | APTV | Sep 3, 2024 | 70.11 | -1.99 |
Aptorum Group A | APM | Sep 3, 2024 | 3.03 | +1.34 |
Aptose Biosciences | APTO | Sep 3, 2024 | 0.41 | +0.32 |
APx Acquisition I A | APXI | Sep 3, 2024 | 11.65 | 0.00 |
APx Acquisition I Unit | APXIU | Sep 3, 2024 | 11.61 | 0.00 |
Apyx Medical | APYX | Sep 3, 2024 | 1.35 | +1.50 |
Aqua Metals | AQMS | Sep 3, 2024 | 0.20 | -7.17 |
AquaBounty Technologies | AQB | Sep 3, 2024 | 1.02 | -0.49 |
Aquaron Acquisition | AQU | Sep 3, 2024 | 11.07 | 0.00 |
Aquaron Acquisition Units | AQUNU | Sep 3, 2024 | 11.70 | +0.60 |
Aquestive Therapeutics | AQST | Sep 3, 2024 | 4.19 | -7.51 |
Aramark | ARMK | Sep 3, 2024 | 36.30 | -0.90 |
ARB IOT Group | ARBB | Sep 3, 2024 | 0.31 | -3.36 |
Arbe Robotics | ARBE | Sep 3, 2024 | 1.96 | -2.00 |
Arbor Realty Trust | ABR | Sep 3, 2024 | 13.26 | -2.50 |
Arbor Realty Trust D Pref | ABR-D | Sep 3, 2024 | 17.75 | -0.78 |
Arbor Realty Trust E Pref | ABR-E | Sep 3, 2024 | 17.65 | -1.34 |
Arbor Realty Trust F Pref | ABR-F | Sep 3, 2024 | 18.40 | -0.65 |
Arbutus Biopharma | ABUS | Sep 3, 2024 | 3.99 | +3.10 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.